Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY5R | Q15761 | 2/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | PRF1 | P14222 | 7/20 | 0.33 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.32 |
| ▸ | GLA | P06280 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | CA12 | O43570 | 2/20 | 0.31 |
| ▸ | CA1 | P00915 | 2/20 | 0.31 |
| ▸ | CA2 | P00918 | 2/20 | 0.31 |
| ▸ | CA9 | Q16790 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13443614 | 0.91 | NPY5R (0.38) | NPY5RALDH1A1PDK2KDM4EMAPT | |
| SCHEMBL13443588 | 0.90 | NPY5R (0.37) | NPY5RALDH1A1PDK2KDM4EMAPT | |
| SCHEMBL13443581 | 0.90 | NPY5R (0.37) | NPY5RALDH1A1PDK2KDM4EMAPT | |
| SCHEMBL13443692 | 0.88 | PDK2 (0.36) | NPY5RALDH1A1PRF1PDK2KDM4E | |
| SCHEMBL13443784 | 0.88 | — | — | |
| SCHEMBL13443602 | 0.87 | NPY5R (0.37) | NPY5RALDH1A1PDK2KDM4ENPC1 | |
| SCHEMBL13463377 | 0.86 | — | — | |
| SCHEMBL13443689 | 0.85 | PDK2 (0.34) | NPY5RALDH1A1PDK2KDM4EMAPT | |
| SCHEMBL13443772 | 0.84 | NPY5R (0.34) | NPY5RALDH1A1KDM4E | |
| SCHEMBL12109612 | 0.84 | ALDH1A1 (0.33) | NPY5RALDH1A1PDK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100066241-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2010-03-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100066241-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | IL33, ORMDL3, CCND3 | NPY5R 637/4885ALDH1A1 1298/4885PRF1 3939/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.